InvestorsHub Logo
Followers 1879
Posts 138494
Boards Moderated 5
Alias Born 01/03/2007

Re: HiddenPivots post# 265346

Wednesday, 09/09/2015 9:26:16 AM

Wednesday, September 09, 2015 9:26:16 AM

Post# of 366151
P AFTER EARNINGS: Dave & Buster's (PLAY), up 10.4%... CONN'S (CONN), up 10.2%. ALSO HIGHER: Akebia Therapeutics (AKBA), up 70.3% after Phase 2 Study of Vadadustat achieved its primary objective... AcelRx Pharmaceuticals (ACRX), up 15.7% after ARX-04 met all endpoints in its Phase 3 study... Protalix BioTherapeutics (PLX), up 8.2% after reporting positive Phase I/II clinical data on 1mg/kg cohort of PRX-102... Pluristem Therapeutics (PSTI), up 5.3% following meeting with FDA. LOWER: Tetraphase (TTPH), down 79% after the eravacycline phase 3 clinical trial did not meet its primary endpoint... Aquinox Pharmaceuticals (AQXP), down 11.2% after announcing that it intends to offer $75M of common stock... MannKind (MNKD), down 7.9% after being downgraded to Underweight from Neutral at Piper Jaffray... Cheniere Energy (LNG), down 3.7% after Jim Chanos announced a short position in the company, while on CNBC

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.